U.S. Paper and Forestry Products Stock News

DorianG (LPG) is back in focus after reporting fourth quarter and full year results on May 20, 2026, with sales and net income figures that differ sharply from the prior year. See our latest analysis for DorianG. The share price has pulled back almost 9% over the past week and slipped around 1% in the latest session, yet a 65% year to date share price return and very large 5 year total shareholder return suggest momentum has been strong over a longer horizon. If this earnings story has you...

On 2 June 2026, Aptiv PLC announced an expanded collaboration with NVIDIA to evolve Jetson platforms, including next-generation Jetson Thor, into commercially supported, long-lifecycle edge AI systems with enhanced security, Linux stability, and regulatory compliance features for industries ranging from automotive to industrial automation. A distinctive aspect of this collaboration is Aptiv’s role in providing long-term lifecycle management and Cyber Resilience Act-ready Yocto platforms,...

Recently, KBRA assigned preliminary ratings to 58 classes of mortgage-backed certificates from the US$285.8 million EFMT 2026-AE4 RMBS, backed entirely by first-lien loans on non-owner-occupied investor properties and second homes underwritten to agency guidelines, with most of the loans originated and serviced by PennyMac Loan Services, a PennyMac Financial Services subsidiary. This transaction highlights PennyMac’s role as a key originator and servicer in the securitization market for...

Northern Trust recently announced leadership changes across its Asset Servicing business in EMEA and globally, while also becoming a founding member of the Financial Services Working Group under the Open Semantic Interchange initiative to advance shared, industry-wide data standards. Together, these moves highlight how Northern Trust is reshaping both its leadership structure and its role in setting open data frameworks that underpin next-generation AI applications in financial...

Mineralys Therapeutics (MLYS) has drawn fresh attention after recent share price swings, with the stock down 7.3% on the day and softer over the past week and month despite stronger 1-year returns. See our latest analysis for Mineralys Therapeutics. The recent pullback, including a 7.3% one day share price decline to $28.85, contrasts with a much stronger 1 year total shareholder return of 78.31%. This suggests short term momentum has cooled while longer term holders remain well ahead. If you...

Nucor, a major US steel producer, has recently been in focus as it benefits from strong technical indicators and supportive tariff policies. An interesting angle for investors is how the combination of bullish technical signals and favorable policy conditions is shaping expectations for Nucor’s revenue and earnings profile. Next, we’ll examine how this mix of strong technical momentum and tariff support influences Nucor’s broader investment narrative. Capitalize on the AI infrastructure...

In late May 2026, Incyte reported that its pivotal Phase 3 frontMIND trial showed tafasitamab (Monjuvi/Minjuvi) plus lenalidomide and R-CHOP significantly improved progression-free and event-free survival versus R-CHOP alone in previously untreated high-risk diffuse large B-cell lymphoma and high-grade B-cell lymphoma, with data presented at ASCO and published in The Lancet. The results not only reinforced the clinical benefit across key patient subgroups but also supported plans for global...

Marex Group (NasdaqGS:MRX) has agreed to acquire Levmet to expand its footprint in European power and gas trading. The deal adds Levmet's physical and derivatives trading capabilities to Marex's existing commodities platform. The acquisition is intended to broaden Marex's earnings base by adding new products and regional exposure. Marex Group, trading at around $51.0, has had a mixed recent run, with the stock down 6.0% over the past week and down 2.8% over the past month, while still up...

Recently, Bank First Corporation was flagged as one of the least appealing small-cap financial stocks after receiving an F valuation grade driven by a relatively high P/E ratio and weaker metrics than sector peers. While some insiders have been buying shares and long-term signals appear constructive, AI-driven trading models highlight soft near- and mid-term sentiment and recommend cautious, risk-managed positioning. We will now examine how Bank First’s weak short- to mid-term sentiment,...

Why Credo’s latest earnings triggered a fresh debate Credo Technology Group Holding (CRDO) has drawn fresh attention after reporting record fourth quarter and full year results, driven by AI data center connectivity demand and a rapidly expanding optical product portfolio. The company delivered earnings and revenue above consensus expectations and guided to continued strength in the coming fiscal year, yet the stock’s sharp post earnings swings show investors are actively debating how long...

Recent performance snapshot International Paper (IP) has attracted fresh attention after recent price moves, with the stock up about 0.4% over the past day, 5.9% over the past week and 6.5% over the past month. Those gains sit against a weaker backdrop, with the stock down about 20.5% over the past 3 months and 15.9% year to date, and showing a 25.1% decline over the past year. See our latest analysis for International Paper. Putting this together, International Paper’s recent 1 month share...

Plug Power (PLUG) has drawn fresh attention after confirming a final investment decision for the 30 megawatt Barrow Green Hydrogen project in the UK, where it will supply GenEco PEM electrolyzers. See our latest analysis for Plug Power. Recent news around Barrow and upcoming investor conferences in New York have arrived alongside strong share price momentum. Plug Power’s share price is up 31.51% over the past month and 83.41% year to date, while the 1-year total shareholder return is very...

Apogee Therapeutics recently reported positive 16-week Part B Phase 2 APEX data for its anti‑IL‑13 antibody zumilokibart in moderate‑to‑severe atopic dermatitis, while also outlining an extensive late‑stage development plan across atopic dermatitis, asthma and eosinophilic esophagitis. At the same time, Apogee entered a financing collaboration with Blackstone Life Sciences for up to US$1.30 billion in flexible, largely non‑dilutive capital tied to future zumilokibart sales, reshaping its...

A securities fraud class action lawsuit has been filed against Merck (NYSE:MRK) over alleged misleading statements about product performance and competition in its Animal Health segment. The complaint centers on claims that Merck did not fully disclose product adoption declines, competitive losses, and market share erosion within Animal Health. The case introduces a new legal and reputational overhang for Merck that is separate from recent focus on valuation, oncology assets, and product...

In the past week, AngloGold Ashanti reported that softer gold prices, linked to a stronger US dollar and shifting interest-rate expectations, weighed on the stock as investors reassessed exposure to gold-linked equities amid geopolitical and inflation concerns. This move occurred against a backdrop of record free cash flow, an interim dividend, and a proposed share repurchase program, underscoring how external macro forces can outweigh supportive company-level cash returns in the short...

Recently, Rackspace Technology announced a memorandum of understanding with AMD to integrate Instinct GPUs and EPYC CPUs into a fully managed, governed enterprise AI cloud, while expanding AI collaborations with partners such as Palantir and Uniphore for regulated and sovereign workloads. This move highlights Rackspace’s push to become a key provider of compliant, higher-value AI and cloud services for tightly regulated industries rather than supporting isolated AI experiments. We’ll now...

Activist pressure meets management response at Flowserve Flowserve (FLS) is in focus after activist investor Starboard Value LP challenged the company’s execution, prompting a detailed management response highlighting operational progress, capital deployment moves and reaffirmed financial targets through 2026 and 2030. See our latest analysis for Flowserve. After a recent pullback that left the 90 day share price return down 7.97%, Flowserve’s stock has regained momentum with a 6.49% 1 month...

Wondering if Palantir Technologies at around US$152 per share is priced for perfection or still offers value? This article walks through the key signals investors are watching. The stock has had a mixed run, with an 11.4% gain over the last week and a 5.6% gain over the last month, set against a year to date decline of 9.3%, a 14.3% return over the past year and a very large return over the last three years. Recent headlines have focused heavily on Palantir's role in artificial intelligence...

Netflix (NFLX) is drawing fresh attention after extending its video podcast partnership with iHeartMedia, bringing The Breakfast Club to Netflix as a live, weekday show, alongside new licensing deals for family entertainment franchises. See our latest analysis for Netflix. Despite expanding into live podcasts and consumer products, recent sentiment has cooled. The 30-day share price return is down 9.48% and the 1-year total shareholder return is down 31.58%, while the 3-year total shareholder...

Prudential Financial (NYSE:PRU) has launched its Elevate suite of retirement products. The new offering is tailored specifically for the independent marketing organization channel. The rollout is designed to expand access to financial advisors who work through these organizations. For investors watching the retirement and insurance space, Elevate sits at the core of what Prudential Financial does, helping clients plan and fund retirement. Independent marketing organizations are an important...

Hycroft Mining Holding (HYMC) has released a detailed S-K 1300 Technical Report Summary and Initial Assessment for its Nevada Hycroft Mine, outlining project economics, a 51-year mine plan, and substantial gold and silver resources. See our latest analysis for Hycroft Mining Holding. The S-K 1300 report and leadership changes land at a time when Hycroft Mining Holding’s share price has been volatile, with a 1-day share price return of 2.98% and year to date share price return of 38.61%, but a...

Amkor Technology recently reinforced its commitment to expanding advanced semiconductor packaging and test capabilities in the United States by securing an additional 67-acre parcel adjacent to its 104-acre Peoria, Arizona campus, which is being developed to support large-scale, leading-edge operations across AI, high-performance computing, automotive, and communications markets. This move underlines Amkor’s role as one of the few U.S. providers able to offer large-scale advanced packaging...

Rithm Capital overview and recent performance snapshot Rithm Capital (RITM) has drawn investor attention after recent share price moves, with the stock at $9.25 and returns down around 6% over the past month and 5% over the past 3 months. As an asset manager focused on real estate, credit, and financial services, Rithm Capital generates all of its $4,240.53m in revenue in the United States and operates across several segments that can respond differently to market and rate conditions. See our...

Wondering whether Textron at around US$91.37 is offering good value right now, or if the easy money has already been made. The stock is up 22.8% over the past year and 44.1% over three years. However, it is down 1.4% over the last week and 3.5% over the past month, with a 5.0% gain year to date. Recent headlines around Textron have focused on its position in capital goods and aerospace and defense, with attention on how the company is positioned against peers and broader industry trends...